Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271180 · ClinicalTrials.gov registry record
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
A clinical trial of Heart Failure and Bradycardia, sponsored by Medtronic.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 20
- Study locations
NCT00271180 is a study of Heart Failure and Bradycardia that is actively recruiting participants, run by Medtronic. The registered enrollment target is 20,000 participants, above the 1,999-participant average among 397 other Heart Failure trials with a reported enrollment target (901% higher). The trial reports 20 study locations across 6 states.
The verdict
NCT00271180, a study of Heart Failure and Bradycardia, is actively recruiting participants, sponsored by Medtronic.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Conditions Studied
Interventions
- DEVICE Device
Study Locations (20)
California
- - Bakersfield
- - Chula Vista
- - La Jolla
- - Los Angeles
- - Palm Springs
- - Rancho Mirage
- - Redwood City
- - Salinas
- - San Diego
- - Stanford
- - Torrance
- - Van Nuys
- - Ventura
Arkansas
- - Jonesboro
- - Little Rock
Colorado
- - Aurora
- - Centennial
Alabama
- - Birmingham
Alaska
- - Anchorage
Arizona
- - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 1983-01 |
| Est. Completion | 2040-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271180
The ClinicalTrials.gov registry entry for NCT00271180 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,999-participant average among 397 other Heart Failure trials with a reported enrollment target (901% higher). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Device is the first listed.
NCT00271180 reports 20 study locations spanning 6 distinct geographic areas - top geographies include California, Arkansas, Colorado.
Frequently Asked Questions
What is clinical trial NCT00271180 about?
NCT00271180 is a clinical study titled "Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products". The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
What is the current status of trial NCT00271180?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 1983-01. Estimated completion is 2040-12.
What conditions does trial NCT00271180 study?
This clinical trial studies the following conditions: Heart Failure, Bradycardia, Arrhythmia, Sinus Tachycardia.
What interventions are being tested in trial NCT00271180?
The interventions under investigation include: Device (DEVICE).
Who is sponsoring clinical trial NCT00271180?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271180 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.